Stay updated on De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial
Sign up to get notified when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.

Latest updates to the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page
- Check3 days agoChange DetectedA notice announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check10 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check17 days agoChange DetectedThe site footer now displays revision v3.7.1 instead of v3.7.0 on the 403 error page.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content. This means the NCT03715946 study details are no longer accessible on the page.SummaryDifference24%

- Check59 days agoChange DetectedThe page’s revision tag was updated from v3.6.5 to v3.6.6, indicating a new build/revision. This change reflects an internal version update rather than a content or feature modification.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page revision updated to v3.6.5, representing an incremental backend/template update rather than a change to the displayed study information.SummaryDifference0.0%

Stay in the know with updates to De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.